UK-based Neurofenix raises €7 million for its digital platform that takes a patient-centric approach to rehabilitation

Published on August 30, 2022

Neurofenix, a healthtech startup with roots in the UK, has picked up a capital investment of €7 million to build out its product line, and kickstart clinical trials in the US. The startup is taking a pioneering patient-centric approach to recovery and at-home therapy that is proving to be more engaging and supportive.  While healthcare…

This content is for members only. Visit the site and log in/register to read.

The post UK-based Neurofenix raises €7 million for its digital platform that takes a patient-centric approach to rehabilitation appeared first on EU-Startups.